A radical shift in the diagnostic approach to diffuse gliomas
Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both m...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Rajesh Panth [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Journal of Pathology of Nepal - Association of Clinical Pathologists of Nepal, 2017, 10(2020), 1, Seite 1663-1674 |
|---|---|
| Übergeordnetes Werk: |
volume:10 ; year:2020 ; number:1 ; pages:1663-1674 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.3126/jpn.v10i1.28947 |
|---|
| Katalog-ID: |
DOAJ075978512 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ075978512 | ||
| 003 | DE-627 | ||
| 005 | 20230503103027.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3126/jpn.v10i1.28947 |2 doi | |
| 035 | |a (DE-627)DOAJ075978512 | ||
| 035 | |a (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RB1-214 | |
| 100 | 0 | |a Rajesh Panth |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A radical shift in the diagnostic approach to diffuse gliomas |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. | ||
| 650 | 4 | |a gliomas; idh; 1p/19q-codeletion; | |
| 653 | 0 | |a Pathology | |
| 773 | 0 | 8 | |i In |t Journal of Pathology of Nepal |d Association of Clinical Pathologists of Nepal, 2017 |g 10(2020), 1, Seite 1663-1674 |w (DE-627)1760637777 |x 20910908 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2020 |g number:1 |g pages:1663-1674 |
| 856 | 4 | 0 | |u https://doi.org/10.3126/jpn.v10i1.28947 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/806fe522cfe2446e98161366eecf38cd |z kostenfrei |
| 856 | 4 | 0 | |u https://www.nepjol.info/index.php/JPN/article/view/28947 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2091-0797 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2091-0908 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2020 |e 1 |h 1663-1674 | ||
| author_variant |
r p rp |
|---|---|
| matchkey_str |
article:20910908:2020----::rdclhfiteigotcpraho |
| hierarchy_sort_str |
2020 |
| callnumber-subject-code |
RB |
| publishDate |
2020 |
| allfields |
10.3126/jpn.v10i1.28947 doi (DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd DE-627 ger DE-627 rakwb eng RB1-214 Rajesh Panth verfasserin aut A radical shift in the diagnostic approach to diffuse gliomas 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. gliomas; idh; 1p/19q-codeletion; Pathology In Journal of Pathology of Nepal Association of Clinical Pathologists of Nepal, 2017 10(2020), 1, Seite 1663-1674 (DE-627)1760637777 20910908 nnns volume:10 year:2020 number:1 pages:1663-1674 https://doi.org/10.3126/jpn.v10i1.28947 kostenfrei https://doaj.org/article/806fe522cfe2446e98161366eecf38cd kostenfrei https://www.nepjol.info/index.php/JPN/article/view/28947 kostenfrei https://doaj.org/toc/2091-0797 Journal toc kostenfrei https://doaj.org/toc/2091-0908 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 1663-1674 |
| spelling |
10.3126/jpn.v10i1.28947 doi (DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd DE-627 ger DE-627 rakwb eng RB1-214 Rajesh Panth verfasserin aut A radical shift in the diagnostic approach to diffuse gliomas 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. gliomas; idh; 1p/19q-codeletion; Pathology In Journal of Pathology of Nepal Association of Clinical Pathologists of Nepal, 2017 10(2020), 1, Seite 1663-1674 (DE-627)1760637777 20910908 nnns volume:10 year:2020 number:1 pages:1663-1674 https://doi.org/10.3126/jpn.v10i1.28947 kostenfrei https://doaj.org/article/806fe522cfe2446e98161366eecf38cd kostenfrei https://www.nepjol.info/index.php/JPN/article/view/28947 kostenfrei https://doaj.org/toc/2091-0797 Journal toc kostenfrei https://doaj.org/toc/2091-0908 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 1663-1674 |
| allfields_unstemmed |
10.3126/jpn.v10i1.28947 doi (DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd DE-627 ger DE-627 rakwb eng RB1-214 Rajesh Panth verfasserin aut A radical shift in the diagnostic approach to diffuse gliomas 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. gliomas; idh; 1p/19q-codeletion; Pathology In Journal of Pathology of Nepal Association of Clinical Pathologists of Nepal, 2017 10(2020), 1, Seite 1663-1674 (DE-627)1760637777 20910908 nnns volume:10 year:2020 number:1 pages:1663-1674 https://doi.org/10.3126/jpn.v10i1.28947 kostenfrei https://doaj.org/article/806fe522cfe2446e98161366eecf38cd kostenfrei https://www.nepjol.info/index.php/JPN/article/view/28947 kostenfrei https://doaj.org/toc/2091-0797 Journal toc kostenfrei https://doaj.org/toc/2091-0908 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 1663-1674 |
| allfieldsGer |
10.3126/jpn.v10i1.28947 doi (DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd DE-627 ger DE-627 rakwb eng RB1-214 Rajesh Panth verfasserin aut A radical shift in the diagnostic approach to diffuse gliomas 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. gliomas; idh; 1p/19q-codeletion; Pathology In Journal of Pathology of Nepal Association of Clinical Pathologists of Nepal, 2017 10(2020), 1, Seite 1663-1674 (DE-627)1760637777 20910908 nnns volume:10 year:2020 number:1 pages:1663-1674 https://doi.org/10.3126/jpn.v10i1.28947 kostenfrei https://doaj.org/article/806fe522cfe2446e98161366eecf38cd kostenfrei https://www.nepjol.info/index.php/JPN/article/view/28947 kostenfrei https://doaj.org/toc/2091-0797 Journal toc kostenfrei https://doaj.org/toc/2091-0908 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 1663-1674 |
| allfieldsSound |
10.3126/jpn.v10i1.28947 doi (DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd DE-627 ger DE-627 rakwb eng RB1-214 Rajesh Panth verfasserin aut A radical shift in the diagnostic approach to diffuse gliomas 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. gliomas; idh; 1p/19q-codeletion; Pathology In Journal of Pathology of Nepal Association of Clinical Pathologists of Nepal, 2017 10(2020), 1, Seite 1663-1674 (DE-627)1760637777 20910908 nnns volume:10 year:2020 number:1 pages:1663-1674 https://doi.org/10.3126/jpn.v10i1.28947 kostenfrei https://doaj.org/article/806fe522cfe2446e98161366eecf38cd kostenfrei https://www.nepjol.info/index.php/JPN/article/view/28947 kostenfrei https://doaj.org/toc/2091-0797 Journal toc kostenfrei https://doaj.org/toc/2091-0908 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 1663-1674 |
| language |
English |
| source |
In Journal of Pathology of Nepal 10(2020), 1, Seite 1663-1674 volume:10 year:2020 number:1 pages:1663-1674 |
| sourceStr |
In Journal of Pathology of Nepal 10(2020), 1, Seite 1663-1674 volume:10 year:2020 number:1 pages:1663-1674 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
gliomas; idh; 1p/19q-codeletion; Pathology |
| isfreeaccess_bool |
true |
| container_title |
Journal of Pathology of Nepal |
| authorswithroles_txt_mv |
Rajesh Panth @@aut@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
1760637777 |
| id |
DOAJ075978512 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ075978512</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503103027.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3126/jpn.v10i1.28947</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ075978512</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ806fe522cfe2446e98161366eecf38cd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB1-214</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Rajesh Panth</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A radical shift in the diagnostic approach to diffuse gliomas</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gliomas; idh; 1p/19q-codeletion;</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pathology</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Pathology of Nepal</subfield><subfield code="d">Association of Clinical Pathologists of Nepal, 2017</subfield><subfield code="g">10(2020), 1, Seite 1663-1674</subfield><subfield code="w">(DE-627)1760637777</subfield><subfield code="x">20910908</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1663-1674</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3126/jpn.v10i1.28947</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/806fe522cfe2446e98161366eecf38cd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.nepjol.info/index.php/JPN/article/view/28947</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2091-0797</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2091-0908</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2020</subfield><subfield code="e">1</subfield><subfield code="h">1663-1674</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Rajesh Panth |
| spellingShingle |
Rajesh Panth misc RB1-214 misc gliomas; idh; 1p/19q-codeletion; misc Pathology A radical shift in the diagnostic approach to diffuse gliomas |
| authorStr |
Rajesh Panth |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760637777 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RB1-214 |
| illustrated |
Not Illustrated |
| issn |
20910908 |
| topic_title |
RB1-214 A radical shift in the diagnostic approach to diffuse gliomas gliomas; idh; 1p/19q-codeletion |
| topic |
misc RB1-214 misc gliomas; idh; 1p/19q-codeletion; misc Pathology |
| topic_unstemmed |
misc RB1-214 misc gliomas; idh; 1p/19q-codeletion; misc Pathology |
| topic_browse |
misc RB1-214 misc gliomas; idh; 1p/19q-codeletion; misc Pathology |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Journal of Pathology of Nepal |
| hierarchy_parent_id |
1760637777 |
| hierarchy_top_title |
Journal of Pathology of Nepal |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760637777 |
| title |
A radical shift in the diagnostic approach to diffuse gliomas |
| ctrlnum |
(DE-627)DOAJ075978512 (DE-599)DOAJ806fe522cfe2446e98161366eecf38cd |
| title_full |
A radical shift in the diagnostic approach to diffuse gliomas |
| author_sort |
Rajesh Panth |
| journal |
Journal of Pathology of Nepal |
| journalStr |
Journal of Pathology of Nepal |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
txt |
| container_start_page |
1663 |
| author_browse |
Rajesh Panth |
| container_volume |
10 |
| class |
RB1-214 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Rajesh Panth |
| doi_str_mv |
10.3126/jpn.v10i1.28947 |
| title_sort |
radical shift in the diagnostic approach to diffuse gliomas |
| callnumber |
RB1-214 |
| title_auth |
A radical shift in the diagnostic approach to diffuse gliomas |
| abstract |
Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. |
| abstractGer |
Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. |
| abstract_unstemmed |
Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
A radical shift in the diagnostic approach to diffuse gliomas |
| url |
https://doi.org/10.3126/jpn.v10i1.28947 https://doaj.org/article/806fe522cfe2446e98161366eecf38cd https://www.nepjol.info/index.php/JPN/article/view/28947 https://doaj.org/toc/2091-0797 https://doaj.org/toc/2091-0908 |
| remote_bool |
true |
| ppnlink |
1760637777 |
| callnumber-subject |
RB - Pathology |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.3126/jpn.v10i1.28947 |
| callnumber-a |
RB1-214 |
| up_date |
2024-07-03T17:54:11.820Z |
| _version_ |
1803581392761651200 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ075978512</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503103027.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3126/jpn.v10i1.28947</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ075978512</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ806fe522cfe2446e98161366eecf38cd</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB1-214</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Rajesh Panth</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A radical shift in the diagnostic approach to diffuse gliomas</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Astrocytic tumours comprise the majority of central nervous system tumours and they have been traditionally graded as recommended by World Health Organization on the basis of atypia, mitoses, microvascular proliferation and necrosis. The 2016 WHO classification of diffuse gliomas incorporates both molecular and histological criteria to categorize these tumours to better predict behavior. A layered diagnostic format is now the recommended approach with the WHO grade being assigned on histological criteria to be supplemented by molecular characterization once the result of isocitrate dehydrogenase is available. The presence of 1p/19q-codeletion has now been included in the definition of oligodendrogliomas. Oligoastrocytomas have now almost vanished as an entity because they are classified as either astrocytomas or oligodendrogliomas after molecular testing. Tests have to be modified in resource limited settings to reach a molecular diagnosis based on new scientific literature and research.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gliomas; idh; 1p/19q-codeletion;</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pathology</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Pathology of Nepal</subfield><subfield code="d">Association of Clinical Pathologists of Nepal, 2017</subfield><subfield code="g">10(2020), 1, Seite 1663-1674</subfield><subfield code="w">(DE-627)1760637777</subfield><subfield code="x">20910908</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1663-1674</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3126/jpn.v10i1.28947</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/806fe522cfe2446e98161366eecf38cd</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.nepjol.info/index.php/JPN/article/view/28947</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2091-0797</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2091-0908</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2020</subfield><subfield code="e">1</subfield><subfield code="h">1663-1674</subfield></datafield></record></collection>
|
| score |
7.399809 |